Long-term measles-induced immunomodulation increases overall childhood infectious disease mortality.
Mina MJ, Metcalf CJ, de Swart RL, Osterhaus AD, Grenfell BT.
Science. 2015 May 8;348(6235):694-9. doi: 10.1126/science.aaa3662. Epub 2015 May 7.
[Hemorrhagic measles].
Bolletti M, Cadrobbi P.
G Mal Infett Parassit. 1967 Apr;19(4):229-31.
Measles: is it still a threat?
Moten M, Phillips A, Saliba V, Harding N, Sibal B.
Br J Gen Pract. 2018 Sep;68(674):404-405. doi: 10.3399/bjgp18X697961. Epub 2018 Jul 2.
Measles immunometrics.
Pierson TC, Yewdell JW.
Proc Natl Acad Sci U S A. 2012 Sep 11;109(37):14724-5. doi: 10.1073/pnas.1212243109. Epub 2012 Aug 30.
Measles virus persistence and its consequences.
Griffin DE.
Curr Opin Virol. 2020 Apr;41:46-51. doi: 10.1016/j.coviro.2020.03.003. Epub 2020 May 5.
Hemorrhagic complications of measles.
KILIC N.
Arch Pediatr (N Y). 1958 Jun;75(6):266-8.
[Measles after MMR-vaccination].
van Grootveld R, Klitsie LM, van der Kaay DCM, Vossen ACTM, Dijkmans AC.
Ned Tijdschr Geneeskd. 2017;161:D1177.
Measles is Back - Considerations for laboratory diagnosis.
Dunn JJ, Baldanti F, Puchhammer E, Panning M, Perez O, Harvala H; Pan American Society for Clinical Virology (PASCV) Clinical Practice and Public Policy Committee and the European Society for Clinical Virology (ESCV) Executive Committee.
J Clin Virol. 2020 Jul;128:104430. doi: 10.1016/j.jcv.2020.104430. Epub 2020 May 13.
Immunological landscape of human lymphoid explants during measles virus infection.
Acklin JA, Patel AR, Kurland AP, Horiuchi S, Moss AS, DeGrace EJ, Ikegame S, Carmichael J, Kowdle S, Thibault PA, Imai N, Ueno H, Tweel B, Johnson JR, Rosenberg BR, Lee B, Lim JK.
JCI Insight. 2024 Jul 25;9(17):e172261. doi: 10.1172/jci.insight.172261.
Mitigating measles outbreaks in West Africa post-Ebola.
Truelove SA, Moss WJ, Lessler J.
Expert Rev Anti Infect Ther. 2015;13(11):1299-301. doi: 10.1586/14787210.2015.1085305. Epub 2015 Sep 7.
